Qiao, Hongxiang <br/><br/>
A novel therapeutic regimen for hepatic fibrosis using the combination of mesenchymal stem cells and baicalin.  [electronic resource] 

 -  Die Pharmazie  Jan 2011 
 - 37-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0031-7144 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blotting, Western<br/>Carbon Tetrachloride Poisoning--pathology<br/>Cell Differentiation--drug effects<br/>Cell Separation<br/>Combined Modality Therapy<br/>Cytochrome P-450 CYP1A1--metabolism<br/>Enzyme-Linked Immunosorbent Assay<br/>Flavonoids--therapeutic use<br/>Hepatocytes--drug effects<br/>Hydroxyproline--metabolism<br/>Lipoproteins, LDL--metabolism<br/>Liver--pathology<br/>Liver Cirrhosis--chemically induced<br/>Liver Function Tests<br/>Male<br/>Mesenchymal Stem Cell Transplantation<br/>Mesenchymal Stem Cells--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Urea--metabolism